Nachrichten zur Regeneron Pharmaceuticals Inc. Aktie

Regeneron Named on Dow Jones Sustainability World Index for Fourth Consecutive Year

DJSI World recognizes the top 10 percent of most sustainable companies by industry; Regeneron ranked among top three biotechnology companies1…

UK drug regulator warns of eye-related side effects after Sanofi/Regeneron Dupixent therapy

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Regeneron wins FDA priority review for label expansion of dyslipidemia therapy

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

ISA Pharmaceuticals Completes Enrolment in Randomized Double Blind Phase 2 Clinical Trial of ISA101b in HPV16 induced Oropharyngeal Cancer

Study designed to investigate the efficacy and safety of ISA101b added to checkpoint inhibitor therapy in Human Papilloma Virus type…

Insiderhandel: EVP & General Mgr, Industrial verkauft Aktien von Regeneron Pharmaceuticals im Wert von 8.868.260$

Van Plew Daniel P. - Vorstand - Tag der Transaktion: 2022-11-23...…

Regeneron-Aktie: Stürzt der Highflyer bald wieder ab?

Die Aktie von Regeneron Pharmaceuticals (WKN: 881535) ist ein Highflyer aus dem US-Biotech-Sektor und zuletzt meldete das Unternehmen wieder starke…

Regeneron :EC Oks Libtayo As First Immunotherapy In Second Line Recurrent/Metastatic Cervical Cancer

WASHINGTON (dpa-AFX) - Regeneron Pharmaceuticals Inc. (REGN) said that the European Commission approved Libtayo (cemiplimab) as monotherapy for the treatment…

Severe Asthma Digital Marketing Trends Report 2022 Featuring Sanofi, Regeneron, Genentech, Novartis, GSK, AstraZeneca, Amgen, & Teva

DUBLIN, Nov. 21, 2022 /PRNewswire/ -- The "Digital Marketing Trends in Severe Asthma" report has been added to ResearchAndMarkets.coms offering.…

CytomX (CTMX) Stock Surges on Oncology Deal With Regeneron

CytomX (CTMX) gets a boost after its deal with Regeneron for the development of investigational next-generation bispecific immunotherapies....…

CytomX Therapeutics Shares Rally on Regeneron Pact

CytomX Therapeutics Shares Rally on Regeneron Pact...…

Regeneron, CytomX Set Cancer-Therapy Collaboration >REGN CTMX

Regeneron, CytomX Set Cancer-Therapy Collaboration >REGN CTMX...…

Grey Wolf Therapeutics Announces Clinical Supply Agreement with Regeneron for Trial Evaluating GRWD5769 in Combination with Libtayo® (cemiplimab)

Combination of First-in-Class ERAP1 Inhibitor and Anti-PD-1 Monoclonal Antibody to be Studied in Patients with a Range of Advanced Solid…

Regeneron, Sanofi: CHMP Recommends Approval Of Dupixent In The EU

PARIS (dpa-AFX) - Regeneron Pharmaceuticals, Inc. (REGN) and Sanofi announced that the European Medicines Agencys Committee for Medicinal Products for…

Regeneron, Sanofi Get CHMP Backing for Dupixent in Prurigo Nodularis >REGN SNY

Regeneron, Sanofi Get CHMP Backing for Dupixent in Prurigo Nodularis >REGN SNY...…

Regeneron pares gains after PTAB rules against Eylea patent

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Intellia Presents Updated Interim Data from the Cardiomyopathy Arm of Ongoing Phase 1 Study of NTLA-2001, an Investigational CRISPR Therapy for the Treatment of Transthyretin (ATTR) Amyloidosis at the American Heart Association Scientific Sessions 20

CAMBRIDGE, Mass., Nov. 05, 2022 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company…

Regeneron, Bayer Offer More Promising Data for Aging Eye Drug

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Supreme Court to hear Amgen appeal on Repatha spat with Sanofi, Regeneron

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Regeneron (REGN) Q3 Earnings & Sales Beat on Eylea, Dupixent

Regeneron (REGN) tops earnings and sales estimates for the third quarter, driven by its lead drug Eylea and profits from…

Form 10-Q REGENERON PHARMACEUTICAL For: Sep 30

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Regeneron Q3 sales sans COVID products grow on back of blockbuster Eylea

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Regeneron Pharmaceuticals Q3 Profit Decreases, but beats estimates

WASHINGTON (dpa-AFX) - Regeneron Pharmaceuticals (REGN) announced earnings for third quarter that decreased from the same period last year but…

Regeneron Pharmaceuticals Q3 tops earnings and revenue marks

Regeneron Pharmaceuticals Inc. said Thursday its third-quarter net income fell 19% to $1.32 billion or $11.66 a share, from…

Can Regeneron maintain EPS beat run in Q3 as eye care space heats up?

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Final Trades: Boeing, Amazon, Regeneron & more

The "Halftime Report" traders give their top picks to watch for the second half....…

Regeneron Pharmaceuticals: Downgrade

St. Petersburg (www.aktiencheck.de) - Rating-Update: Dane Leone, Analyst von Raymond James, stuft die Aktie von Regeneron Pharmaceuticals Inc. (ISIN: US75886F1075,…

Inmazeb™ (atoltivimab, maftivimab, and odesivimab-ebgn) Wins Prestigious 2022 Prix Galien USA Best Biotechnology Product Award

Inmazeb is the first FDA-approved treatment for Zaire ebolavirus TARRYTOWN, N.Y., Oct. 28, 2022 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ:…

XETR : NEW INSTRUMENT AVAILABLE - 27.10.2022 - US75886F1075

Das Instrument RGO US75886F1075 REGENERON PHARMAC.DL-,001 EQUITY hat seinen ersten Handelstag am 27.10.2022: CONTINUOUS TRADING WITH AUCTIONS, PAG NAM0, SettlCurr…

Regeneron slips as Raymond James downgrades on Eylea concerns

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Regeneron (REGN) Gains But Lags Market: What You Should Know

In the latest trading session, Regeneron (REGN) closed at $747.33, marking a +1.38% move from the previous day....…

Biotech Report: Evotec (EVT) behauptet, MorphoSys (MOR) tiefrot

Biotech-Aktien zeigen sich zum Wochenauftakt überwiegend leichter. Während sich Papiere von Evotec behaupten können, rutschen MorphoSys deutlich ab.…

Regeneron: FDA Grants Pediatric Exclusivity For EYLEA

WASHINGTON (dpa-AFX) - Regeneron Pharmaceuticals, Inc. (REGN) announced the FDA has granted pediatric exclusivity for EYLEA Injection. This extends the…

Regeneron wins six-month pediatric exclusivity for Eylea in U.S. market

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Insiderhandel: EVP Finance CFO verkauft Aktien von Regeneron Pharmaceuticals im Wert von 264.741$

Landry, Robert E. - Vorstand - Tag der Transaktion: 2022-10-17...…

Regeneron Pharmaceuticals: Downgrade

New York (www.aktiencheck.de) - Rating-Update: Joshua Schimmer, Analyst von Evercore ISI, setzt seine Einschätzung für die Aktie von Regeneron Pharmaceuticals Inc.…

Regeneron (REGN) Stock Sinks As Market Gains: What You Should Know

Regeneron (REGN) closed the most recent trading day at $735.96, moving -0.01% from the previous trading session....…

If You Invested $100 In This Stock 20 Years Ago, You Would Have $5,000 Today

Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 20 years by 14.25% on an annualized basis producing an…

Regeneron (REGN) Drug Gets Positive CHMP View for Cervical Cancer

Regeneron (REGN) gets a positive recommendation from CHMP for the label expansion of its oncology drug for treating adult patients…

Analyst Ratings for Regeneron Pharmaceuticals

Regeneron Pharmaceuticals (NASDAQ:REGN) has observed the following analyst ratings within the last quarter: Latest Ratings for REGN …

Biotech Investors Need Patience (And a Strong Stomach)

The sector has been tricky for investors. Regeneron Pharmaceuticals is an example, getting a downgrade to In Line from Outperform…

Regeneron downgraded at Evercore citing eyecare landscape

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Regeneron Pharma: CHMP Adopts Positive Opinion For Libtayo

WASHINGTON (dpa-AFX) - Regeneron Pharmaceuticals, Inc. (REGN) announced the European Medicines Agencys CHMP has adopted a positive opinion for Libtayo…

Regeneron Gets CHMP Backing for Libtayo for Advanced Cervical Cancer >REGN

Regeneron Gets CHMP Backing for Libtayo for Advanced Cervical Cancer >REGN...…

Libtayo® (cemiplimab) Receives Positive CHMP Opinion Recommending Approval to Treat Advanced Cervical Cancer

Recommendation based on a Phase 3 Libtayo trial that was first and only to demonstrate significantly improved survival compared to…

Regeneron: EYLEA SBLA Gets FDA Priority Review

LEVERKUSEN (dpa-AFX) - Regeneron Pharmaceuticals, Inc. (REGN) announced the FDA has accepted for Priority Review the supplemental Biologics License Application…

Sanofi/Regeneron Dupixent shows efficacy in kids with esophagus inflammation in phase 3 trial

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Regeneron Reports Positive Results From Dupixent Phase 3 Trial In 1 To 11 Yrs With EoE

PARIS (dpa-AFX) - Regeneron Pharmaceuticals Inc. (REGN) and Sanofi (SNY, SNYNF) on Tuesday presented late-breaking positive results from a Phase…

Sanofi and Regeneron present more positive data for Dupixent product

...PARIS (Reuters) - Healthcare companies Sanofi and partner......…

Insiderhandel: SVP Controller verkauft Aktien von Regeneron Pharmaceuticals im Wert von 1.381.156$

Fenimore, Christopher R. - Vorstand - Tag der Transaktion: 2022-10-05...…

Regeneron to Report Third Quarter 2022 Financial and Operating Results and Host Conference Call and Webcast on November 3, 2022

TARRYTOWN, N.Y., Oct. 4, 2022 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its third…